Stock listing

Gossamer Bio, Inc.

Selected listing: GOSS · NASDAQ · USD · US

Gossamer Bio, Inc. (NASDAQ:GOSS), Health Technology. Latest release Sep 23, 2026: Gossamer Bio Submits New Drug Application to U.S. FDA for Seralutinib…

GOSS:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:GOSS
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Gossamer Bio, Inc.

Gossamer Bio, Inc. is a public company traded under the ticker GOSS in the American market. Gossamer Bio focuses on developing innovative therapies to address unmet medical needs.

Latest news from Gossamer Bio, Inc.

Gossamer Bio Submits New Drug Application to U.S. FDA for Seralutinib for the Treatment of Pulmonary Arterial Hypertension

September 23, 2026

Gossamer Bio Appoints Greg Ciongoli to Board of Directors

September 16, 2026

Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split

September 11, 2026

Gossamer Bio Announces 1-for-80 Reverse Stock Split

September 9, 2026

Gossamer Bio to Present at Cantor Global Healthcare Conference

September 4, 2026

All Gossamer Bio, Inc. news →

Events

Replays

Gossamer Bio, Inc. (GOSS) Q1 2026 Earnings Call
Mon, May 18, 2026 · 08:00 AM ET
Watch
Gossamer Bio, Inc. (GOSS) Q1 2025 Earnings Call
Thu, May 15, 2025 · 04:30 PM ET
Watch
Gossamer Bio, Inc. (GOSS) Q4 2021 Earnings Call
Thu, Mar 03, 2022 · 04:30 PM ET
Watch

Research Gossamer Bio, Inc.

Gossamer Bio, Inc. company profile

View the public company page for Gossamer Bio, Inc. on 6ix.

Gossamer Bio, Inc. news

Read company news and market updates connected to Gossamer Bio, Inc..

Gossamer Bio, Inc. investor events

Find investor webinars, events, and replay context for Gossamer Bio, Inc..